Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

AbCellera Biologics Appoints Dr. Stephen Quake to Board

Abcellera (NASDAQ: ABCL) has announced the appointment of Dr. Stephen Quake to its board of directors as an independent director. Dr. Quake is a distinguished scientist, inventor, and entrepreneur. Abcellera welcomed Dr. Quake to its board, recognizing his significant contributions across diverse fields. Today the company's shares have moved -1.0% to a price of $3.97. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS